RHUMBLINE ADVISERS

Position in CABA — Cabaletta Bio, Inc.

CIK 1115418 BOSTON, MA

Position in CABA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$409,400

+$324,378 QoQ

Shares Held

131,640

+114.4% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#59

of 139 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. CABA ranks #200 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$409,400	131,640	+114.4%	Shares	Sole	2026-08-12
2025-03-31	$85,022	61,388	-3.2%	Shares	Sole	2025-05-29
2024-12-31	$143,965	63,421	+4.7%	Shares	Sole	2025-05-29
2024-09-30	$285,890	60,570	-2.1%	Shares	Sole	2024-11-12
2024-06-30	$462,862	61,880	+35.7%	Shares	Sole	2024-08-01
2024-03-31	$778,038	45,606	+3.3%	Shares	Sole	2024-05-09
2023-12-31	$1,002,136	44,147	+3.6%	Shares	Sole	2024-02-08
2023-09-30	$648,402	42,602	+47.0%	Shares	Sole	2023-11-09
2023-06-30	$374,131	28,980	+97.2%	Shares	Sole	2023-08-08
2021-03-31	$163,103	14,694	-4.9%	Shares	Sole	2021-05-06
2020-12-31	$192,865	15,454	+21.3%	Shares	Sole	2021-02-10
2020-09-30	$138,155	12,745	-15.2%	Shares	Sole	2020-11-12
2020-06-30	$167,423	15,029	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.